Table 2 Characteristics of patients with mucinous ovarian cancer with a recurrence free interval > 6 months compared to other histological subtypes at the time of the diagnosis of recurrence.
Mucinous | Other histotypes | p | |
|---|---|---|---|
Number of patients | 20 | 388 | |
Age (years) | 20 | 380 | |
Mean (± s.d.) | 57.6 ± 12.8 | 59.8 ± 10.8 | n.s.* |
Median | 58 | 60.5 | |
Range | 28–78 | 33–97 | |
PS Ecog | 20 | 360 | |
0 | 45.0% | 62.8% | 0.0241** |
1 | 40.0% | 33.9% | |
2 | 15.0% | 3.3% | |
3 | . | . | . |
Recurrence free interval (N) | 17 | 378 | |
6–12 months | 58.8% | 38.9% | n.s.** |
> 12 months | 41.2% | 61.1% | |
median (range) – months: | 10.6 (5–141) | 15.3 (5–160) | n.s.**** |
Number of disease sites | 20 | 335 | |
1 | 25.0% | 44.8% | n.s.** |
> 1 | 75.0% | 55.2% | |
Surgery | 19 | 375 | |
Yes | 26.3% | 20.5% | n.s.*** |
No | 73.7% | 79.5% | |
Result of cytoreductive surgery | 5 | 64 | |
No residual | . | 50.0% | 0.0308*** |
Residual desease | 100.0% | 50.0% | |
Ca 125 | 14 | 247 | n.s.** |
Normal: ≤ 35 | 14.3% | 12.1% | |
> 35 U/ml | 85.7% | 87.9% |